XML 73 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Summary of segment information                      
Total Assets $ 258,029us-gaap_Assets       $ 104,713us-gaap_Assets       $ 258,029us-gaap_Assets $ 104,713us-gaap_Assets  
Net revenues from external customers 22,999us-gaap_Revenues 14,973us-gaap_Revenues 10,608us-gaap_Revenues 15,958us-gaap_Revenues 14,737us-gaap_Revenues 13,005us-gaap_Revenues 9,580us-gaap_Revenues 11,651us-gaap_Revenues 64,538us-gaap_Revenues 48,973us-gaap_Revenues 31,388us-gaap_Revenues
Operating (loss) income                 19,626us-gaap_OperatingIncomeLoss 14,943us-gaap_OperatingIncomeLoss 193us-gaap_OperatingIncomeLoss
Depreciation and amortization expense                 2,657us-gaap_DepreciationDepletionAndAmortization 2,663us-gaap_DepreciationDepletionAndAmortization 2,727us-gaap_DepreciationDepletionAndAmortization
Write-off of in-process research and development                   480lgnd_WriteoffofInProcessResearchandDevelopment  
Income tax (expense) benefit (280)us-gaap_IncomeTaxExpenseBenefit (124)us-gaap_IncomeTaxExpenseBenefit 47us-gaap_IncomeTaxExpenseBenefit (53)us-gaap_IncomeTaxExpenseBenefit (138)us-gaap_IncomeTaxExpenseBenefit (60)us-gaap_IncomeTaxExpenseBenefit (110)us-gaap_IncomeTaxExpenseBenefit (66)us-gaap_IncomeTaxExpenseBenefit (410)us-gaap_IncomeTaxExpenseBenefit (374)us-gaap_IncomeTaxExpenseBenefit 1,191us-gaap_IncomeTaxExpenseBenefit
Interest expense, net                 4,860us-gaap_InterestExpense 2,077us-gaap_InterestExpense 2,924us-gaap_InterestExpense
Gain on sale of Avinza Product Line before income taxes                 0us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax 2,588us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax 3,656us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
Income tax expense from discontinuing operations                     (1,509)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
Ligand                      
Summary of segment information                      
Total Assets 184,215us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
      38,408us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
      184,215us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
38,408us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
 
Net revenues from external customers                 27,174us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
21,436us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
19,582us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Operating (loss) income                 (2,372)us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
253us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
(919)us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Depreciation and amortization expense                 253us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
233us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
222us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Write-off of in-process research and development                   0lgnd_WriteoffofInProcessResearchandDevelopment
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
 
Income tax (expense) benefit                 5,106us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
(419)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
1,096us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Interest expense, net                 4,860us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
2,077us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
2,924us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Gain on sale of Avinza Product Line before income taxes                   2,588us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
3,656us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
Income tax expense from discontinuing operations                     (1,509)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_LigandMember
CyDex                      
Summary of segment information                      
Total Assets 73,814us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
      66,305us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
      73,814us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
66,305us-gaap_Assets
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
 
Net revenues from external customers                 37,364us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
27,537us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
11,806us-gaap_Revenues
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Operating (loss) income                 21,998us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
14,690us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
1,112us-gaap_OperatingIncomeLoss
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Depreciation and amortization expense                 2,404us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
2,430us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
2,505us-gaap_DepreciationDepletionAndAmortization
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Write-off of in-process research and development                   480lgnd_WriteoffofInProcessResearchandDevelopment
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
 
Income tax (expense) benefit                 (5,516)us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
45us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
95us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Interest expense, net                 0us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
0us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
0us-gaap_InterestExpense
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Gain on sale of Avinza Product Line before income taxes                   0us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
0us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember
Income tax expense from discontinuing operations                     $ 0us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ us-gaap_StatementBusinessSegmentsAxis
= lgnd_CydexPharmaceuticalsIncMember